CVE-2020-16222
Last modified
CVE-2020-16222 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.. EPSS estimates a 0.55% chance of exploitation in the next 30 days.
Description
In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.
Metrics
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Philips | Patient Information Center Ix | b.02 |
| Philips | Patient Information Center Ix | c.02 |
| Philips | Patient Information Center Ix | c.03 |
| Philips | Performancebridge Focal Point | a.01 |
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-254-01Third Party Advisory, US Government Resource
- https://us-cert.cisa.gov/ics/advisories/icsma-20-254-01Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2020-16222?
How severe is CVE-2020-16222?
How do I fix CVE-2020-16222?
Are you affected by CVE-2020-16222?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
